Abstract: Use of a substance of formula (I) wherein —R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen (—H), methyl (—CH3), ethyl (—CH2CH3), C3 alkyl, C4 alkyl, C5 alkyl and C6 alkyl, and —X and Y are independently selected from the group consisting of hydrogen (—H), methyl (—CH3), ethyl (—CH2CH3), C3 alkyl, C4 alkyl, C5 alkyl and C6 alkyl, halogen, nitro (—NO2), hydroxy (—OH), methoxy (—OCH3), ethoxy (—OCH2CH3), C3 alkoxy, C4 alkoxy, C5 alkoxy and C6 alkoxy, phenyl (—C6H5), benzyl (—CH2C6H5), and benzyloxy (—OCH2C6H5), (a) for the manufacture of cosmetic compositions and/or topical compositions and/or (b) in cosmetic compositions and/or topical compositions for (i) the lightening of the skin and/or (ii) the whitening of the skin and/or (iii) the reduction of pigmentation of the skin and/or (iv) the reduction of hyperpigmentation of the skin and/or (v) the inhibition of melanogenesis in the skin and/or (vi) the prevention and/or retardation of signs of ageing and/or improving the skin a

Abstract: A cosmetic or pharmaceutical composition includes a peptide parathyroid hormone fragment, derivatives thereof, salts thereof, and combinations thereof, where the peptide fragment conforms to the structure R1-NH-AA-R2 where R1 is selected from the group consisting of —H, a linear or branched, saturated or unsaturated acyl group having from 1 to 24 carbon atoms optionally functionalized with an —OH, —SH, —COOH or —CONH2 group, or a sterol group which is bonded by a functional group with the peptide; where R2 is —OH, —OH functionalized by a linear or branched, saturated or unsaturated alkyl group having from 1 to 24 carbon atoms, or a sterol group; and where AA corresponds completely or partially to the sequence of amino acids according to SEQ ID No. 1 corresponding to the PTH (28 to 34) region.

Abstract: The present invention relates to substances which can be used as cosmetic ingredients, especially for skin whitening and as cosmetic agents against signs of ageing skin. The present invention also relates to the use of such substances for the manufacture of a medicament for the treatment of disorders related to the pigmentation of the skin.

Abstract: The present invention relates to cosmetic compositions comprising sclareolide and hesperidin methyl chalcone (HMC), which can be used especially for the tanning of skin and/or the darkening of hair and/or preventing of greying of hair. The present invention also relates to the use of agents for these purposes.

Abstract: The present invention relates to the cosmetic use of oligopeptides, cosmetic preparations which comprise such oligopeptides as well as certain oligopeptide derivatives themselves.

Abstract: The present invention relates to substances which can be used as cosmetic ingredients, especially for skin whitening and as cosmetic agents against signs of ageing skin. The present invention also relates to the use of such substances for the manufacture of a medicament for the treatment of disorders related to the pigmentation of the skin. The invention furthermore relates to specific substances.

Abstract: Disclosed is a method for preventing and/or soothing dry or sensitive skin against external stresses, comprising contacting the skin with a composition including an agent that decreases the release of granulocyte-macrophage colony-stimulating factor (GMCSF) from keratinocytes in the skin, wherein under conditions of external stress, dry or sensitive skin is soothed and/or prevented. Agents that decrease the release of GMCSF include silybin, piperine, tetrahydropiperine, nortrachelogenine, rhapontin, arctiin, artigenin and mixtures thereof. Also disclosed is a method of identifying an agent that decreases the level of GMCSF released from keratinocytes.

Abstract: The invention is directed to a skin-whitening active comprising at least one sugar fatty acid ester and at least one plant extract selected from the group consisting of extracts of Waltheria indica, extracts of Pisum sativum and mixtures thereof. The invention is further directed to cosmetic compositions comprising such a skin-whitening active.

Abstract: Oligopeptides according to formula (I) and/or (II), R1-Tyr-Pro-Trp-Phe-NH2 (I); R1-Tyr-Pro-Phe-Phe-NH2 (II), wherein R1 is linked to the NH2-group of the amino-terminal part of Tyr and is selected from the group consisting of —H; a linear saturated or unsaturated or branched saturated or unsaturated acyl group having 1 to 24 carbon atoms, which may be functionalized by a —OH, —SH, —COOH or —CONH2 group; a sterol or a sphingolipid group which is linked to the amino terminal part of Tyr via a bifunctional linker are disclosed. Cosmetic compositions containing the oligopeptides are also disclosed.

Abstract: Esters of flavonoids, including flavones, flavonols, flavanones, flavanols, flavanolols, isoflavones, anthocyanins, proanthocyanidins, chalcones, aurones and hydroxycoumarins conjugated by an ester bond to a ?-substituted C6 to C22 fatty acid are provided. The esters may be used in cosmetic, pharmaceutical, and nutritional preparations.

Abstract: The present invention is concerned with acyl ribonucleosides and with acyl deoxyribonucleosides. It is furthermore concerned with an enzymatic process for the manufacture of acyl ribonucleosides and of acyl deoxyribonucleosides. It is furthermore concerned with the use of acyl ribonucleosides and of acyl deoxyribonucleosides for cosmetic and for pharmaceutical purposes and with their use as a food supplement for humans or animals. It is furthermore concerned with compositions containing acyl ribonucleosides and acyl deoxyribonucleosides, whereby these compositions are suitable for cosmetic or for pharmaceutical purposes or as food supplement.

Abstract: Disclosed is a method for enzymatic synthesis of esters of flavonoid and flavonoid derivatives, according to which a reaction medium containing an organic solvent, a glycosylated flavonoid or aglycon flavonoid, an acyl group donor, and an enzymatic catalyst is produced, b) additional quantities of flavonoid and/or acyl donor are optionally added during the reaction, and c) the obtained esters are separated from the enzymatic particles and the solvent. The inventive method is characterized by maintaining the concentration of water and/or alcohol which are formed during the reaction to below 150 mM. Advantageously, the molar ratio of flavonoid to acyl donor in the reaction medium is maintained in the range from 0.01 to 20.00 during the reaction.

Abstract: Processes for producing cosmetic and/or pharmaceutical active components which comprise: (a) providing a fermentation broth comprising a plant component selected from the group consisting of plant constituents, plant extracts and mixtures thereof; (b) inoculating the fermentation broth with a microorganism; and (c) fermenting the microorganism-containing fermentation broth to produce an active component; are described along with cosmetic and/or pharmaceutical preparations containing such active components and methods of using the same to treat the skin and/or hair.

Abstract: The invention relates to novel cosmetic preparations containing an effective amount of an extract of germinating plants.

Abstract: A cosmetic or pharmaceutical composition containing an active ingredient selected from the group consisting of late embryogenesis abundant proteins, heat shock proteins, and mixtures thereof.

Abstract: Cosmetic and/or pharmaceutical compositions which contain: (a) a Brassicaceae extract; and (b) one or more compounds selected from the group consisting of oil components, emulsifiers, antioxidants and UV/IR protection factors are described, along with methods for preparing and using the same.